Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999-2014

Diabetes Research and Clinical Practice
Anna GuEdgar Argulian

Abstract

The 2013 American College of Cardiology/American Heart Association Guideline defined patients with diabetes aged 40-75 years as a major statin benefit group. We explored the temporal trends and disparities in statin utilization and LDL-C levels among patients with diabetes aged 40-75 years. A total of 4860 patients from the National Health and Nutrition Examination Survey 1999 to 2014 were included in this study. Differences in statin use and LDL-C levels were explored by patient characteristics. From 1999-2002 to 2011-2014, the prevalence of statin use increased from 26.2% to 49.5% (Ptrend < 0.001). This was accompanied by a continuous decrease in the mean LDL-C level (from 115.8 mg/dL to 103.3 mg/dL, Ptrend < 0.001). The use of guideline-defined high-potency statin medications (atorvastatin and rosuvastatin) remained largely unchanged (from 14.0% to 17.9%, Ptrend = 0.55). Statin utilization increased with age. Women and blacks were 10% and 16% less likely to receive statin treatment compared with men and whites, respectively. In comparison with other statin treatment, use of atorvastatin or rosuvastatin was associated with average LDL-C reduction of 8.0 mg/dL. LDL-C levels were significantly higher among women and black patie...Continue Reading

Citations

Jan 31, 2019·Journal of Pharmacy Practice·Robert VincentVishal Patel
Oct 24, 2020·Journal of the American Heart Association·Omar SaeedUlrich P Jorde
Nov 24, 2020·Current Treatment Options in Cardiovascular Medicine·Sujana BallaFatima Rodriguez
Dec 16, 2020·Journal of the American Heart Association·Yi GuoJiang Bian
Mar 2, 2021·Journal of Managed Care & Specialty Pharmacy·José J Hernández-MuñozChandni R Kamdar

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.